Indivior Pharmaceuticals Inc (INDV) Stock Overview
Explore Indivior Pharmaceuticals Inc’s financial performance, market position, analyst ratings, and future outlook.
Indivior Pharmaceuticals Inc (INDV)
Key Financials
Key Financials
Market Cap
4.8B
P/E Ratio
19.13
EPS (TTM)
$1.95
ROE
-1.42%
INDV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Indivior Pharmaceuticals Inc (INDV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 59.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.20.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.13 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.